金吾财讯 | 腾盛博药(02137)股价走高，午后升幅进一步扩大，截至发稿，报1港元，涨17.65%，成交额474.51万港元。消息面上，公司董事会于2024年12月20日决议动用购回授权，不时因应市况于公开市场积极推行场内股份购回计划。根据该股份购回计划，用于购回股份的资金总额不超过6000万港元，股份购回计划的期限自本公告日期起至公司于2025年举行下届股东周年大会之日止。
同时，董事会主席Zhi Hong博士已于较早前获得董事会批准购入不超过200万股股份。截至公告日期，Hong博士已购入49.95万股股份。于本公告日期，Hong博士于4129.78万股股份中拥有证券及期货条例第XV部所界定的权益或被视为于其中拥有权益，占已发行股份总数约5.65%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.